Okta To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday
I'm LongbridgeAI, I can summarize articles.Cantor Fitzgerald raised Okta's price target from $125 to $170, maintaining an Overweight rating. Other analyst updates include Keefe, Bruyette & Woods upgrading Progressive Corp and raising its target; Morgan Stanley upgrading Merck & Co and significantly increasing its target; and Needham raising Analog Devices' target. Conversely, Ascendiant Capital lowered Travelzoo's target. These changes reflect shifting Wall Street outlooks on various tech, healthcare, and insurance stocks.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Keefe, Bruyette & Woods raised the price target for Progressive Corp (NYSE:PGR) from $226 to $250. Keefe, Bruyette & Woods analyst Meyer Shields upgraded the stock from Market Perform to Outperform. Progressive shares closed at $217.27 on Wednesday. See how other analysts view this stock.
- Cantor Fitzgerald boosted Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) price target from $96 to $103. Cantor Fitzgerald analyst Kristen Kluska maintained an Overweight rating. Ultragenyx Pharmaceutical shares closed at $26.24 on Wednesday. See how other analysts view this stock.
- Ascendiant Capital slashed price target for Travelzoo (NASDAQ:TZOO) from $23 to $20. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Travelzoo shares closed at $6.88 on Wednesday. See how other analysts view this stock.
- Needham increased the price target for Analog Devices Inc (NASDAQ:ADI) from $440 to $450. Needham analyst N. Quinn Bolton maintained a Buy rating. Analog Devices shares closed at $373.26 on Wednesday. See how other analysts view this stock.
- Morgan Stanley raised Merck & Co Inc (NYSE:MRK) price target from $116 to $179. Morgan Stanley analyst Terence Flynn upgraded the stock from Equal-Weight to Overweight. Merck shares closed at $152.20 on Wednesday. See how other analysts view this stock.
- BTIG increased Glaukos Corp (NYSE:GKOS) price target from $193 to $202. BTIG analyst Ryan Zimmerman maintained a Buy rating. Glaukos shares closed at $189.55 on Wednesday. See how other analysts view this stock.
- Morgan Stanley raised Moderna Inc (NASDAQ:MRNA) price target from $39 to $89. Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating. Moderna shares closed at $174.38 on Wednesday. See how other analysts view this stock.
- Needham raised the price target for NIQ Global Intelligence PLC (NYSE:NIQ) from $18 to $21. Needham analyst Kyle Peterson maintained a Buy rating. NIQ Global Intelligence shares closed at $18.31 on Wednesday. See how other analysts view this stock.
- Cantor Fitzgerald raised Okta Inc (NASDAQ:OKTA) price target from $125 to $170. Cantor Fitzgerald analyst Jonathan Ruykhaver maintained an Overweight rating. Okta shares closed at $141.21 on Wednesday. See how other analysts view this stock.
- Cantor Fitzgerald raised Rubrik Inc (NYSE:RBRK) price target from $95 to $120. Cantor Fitzgerald analyst Jonathan Ruykhaver maintained an Overweight rating. Rubrik shares closed at $99.78 on Wednesday. See how other analysts view this stock.
Considering buying OKTA stock? Here’s what analysts think:
Photo via Shutterstock